Millennium Pharmaceuticals, Inc. (MLNM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (1507)	5/13/2003 8:20:46 PM
From: Ian@SI	Read Replies (1) of 3044

Millennium to Webcast Conference Call on Recent FDA Approval of Velcade(TM) (bortezomib) for Injection on May 14, 2003 CAMBRIDGE, Mass., May 13 /PRNewswire-FirstCall/ --Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) will hold a live webcast of its conference call at 8:30 a.m. EDT on Wednesday, May 14, 2003. Mark Levin, chairperson and chief executive officer will host the call. He will discuss the Company's recent news regarding approval of VELCADE. The live webcast can be accessed by visiting the Investor section of the Company's website, millennium.com. Following the webcast, an archived version of the call will be available at the same address until May 16, 2003. About Millennium [snip]

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next